Skip to main content
Figure 4 | BMC Medicine

Figure 4

From: A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer

Figure 4

Network of included RCTs for the base case PFS based on Kaplan Meier curves: hormone receptor status. CD, cyclophosphamide + doxorubicin; CMF, cyclophosphamide + methotrexate + 5-fluorouracil; CT, chemotherapy; ER, estrogen receptor; HT, hormonal therapy; MA, megestrol acetate; PFS, progression-free survival; PLD, pegylated liposomal doxorubicin; RCT, randomized controlled trial.

Back to article page